Design and synthesis of CK2 inhibitors

Molecular and Cellular Biochemistry

Volumn 356, Issue 1-2, 2011, Pages 91-96

  Makowska, MaŁgorzata ^a   Łukowska Chojnacka, Edyta ^b   Wińska, Patrycja ^b   Kuś, Agnieszka ^b   Bilińska Chomik, Aleksandra ^b   Bretner, Maria ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

4,5,6,7 tetrabromo 1H benzimidazole derivatives; 4,5,6,7 tetrabromo 1H benzotriazole derivatives; CK2 kinase inhibitors

Indexed keywords

5,6,7 TRIBROMO 4 ETHYL 1H BENZOTRIAZOLE; 5,6,7 TRIBROMO 4 METHYL 1 H BENZOTRIAZOLE; BENZENE; BENZIMIDAZOLE DERIVATIVE; BENZOTRIAZOLE DERIVATIVE; CASEIN KINASE II; HETEROCYCLIC COMPOUND; METHYL GROUP; PROTEIN SERINE THREONINE KINASE INHIBITOR; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME ACTIVITY; IC 50;

BENZIMIDAZOLES; CASEIN KINASE II; DRUG DESIGN; HUMANS; INHIBITORY CONCENTRATION 50; PROTEIN KINASE INHIBITORS; TRIAZOLES;

EID: 84855216036     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0953-8     Document Type: Article

References (29)

1. Jabbour E, Cortes JE, Giles FJ, O'Brien S, Kantarjian HM (2007) Current and emerging treatment options in chronic myeloid leukemia. Cancer 109:2171-2181 (Pubitemid 46801546)
2. Flaherty KT (2007) Sorafenib in renal cell carcinoma. Clin Cancer Res 13:747-752
3. Weisberg E, Manley PW, Breitenstein W, Brüggen J et al (2005) Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 7:129-141 (Pubitemid 40248339)
4. Pierre F, Chua PC, O'Brien SE et al (2011) Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. J Med Chem 54(2):635-654
5. Faust RA, Tawfic S, Davis AT, Bubash LA, Ahmed K (2000) Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro. Head Neck 22(4):341-346 (Pubitemid 30413298)
6. Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC (2001) Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20(25):3247-3257 (Pubitemid 32553677)
7. Pistorius K, Seitz G, Remberger K, Issinger OG (1991) Differential CKII activities in human colorectal mucosa, adenomas and carcinomas. Onkologie 14(3):256-260
8. Stalter G, Siemer S, Becht E, Ziegler M, Remberger K, Issinger OG (1994) Asymmetric expression of protein kinase CK2 sub-units in human kidney tumors. Biochem Biophys Res Commun 202(1):141-147 (Pubitemid 24252576)
9. O-charoenrat P, Rusch V, Talbot SG, Sarkaria I, Viale A, Socci N, Ngai I, Rao P, Singh B (2004) Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung. Clin Cancer Res 10(17):5792-5803 (Pubitemid 39180957)
10. Kim JS, Eom JI, Cheong JW, Choi AJ, Lee JK, Yang WI, Min YH (2007) Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clin Cancer Res 13(3):1019-1028
11. Litchfield DW (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369:1-15 (Pubitemid 36174119)
12. Shi X, Potvin B, Huang T, Hilgard P, Spray DC, Suadicani SO, Wolkoff AW, Stanley P, Stockert RJ (2001) A novel casein kinase 2 α-subunit regulates membrane protein traffic in the human hepatoma cell line HuH-7. J Biol Chem 276:2075-2082 (Pubitemid 32109689)
13. Guerra B, Siemer S, Boldyreff B, Issinger OG (1999) Protein kinase CK2: evidence for a protein kinase CK2beta subunit fraction, devoid of the catalytic CK2alpha subunit, in mouse brain and testicles. FEBS Lett 462(3):353-357
14. Filhol O, Nueda A, Martel V, Gerber-Scokaert D, Benitez MJ, Souchier C, Saoudi Y, Cochet C (2003) Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits. Mol Cell Biochem 23(3):975-987 (Pubitemid 36133515)
15. Pagano MA, Bain J, Kazimierczuk Z, Sarno S, Ruzzene M, Di Maira G, Elliott M, Orzeszko A, Cozza G, Meggio F, Pinna LA (2008) The selectivity of inhibitors of protein kinase CK2: an update. Biochem J 415:353-365
16. Battistutta R (2009) Protein kinase CK2 in health and disease: structural bases of protein kinase CK2 inhibition. Cell Mol Life Sci 66:1868-1889
17. Pagano MA, Poletto G, Di Maira G, Cozza G, Ruzzene M, Sarno S, Bain J, Elliott M, Moro S, Zagotto G, Meggio F, Pinna LA (2007) Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chembiochem 8(1):129-139 (Pubitemid 46121580)
18. Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, Bain J, Elliott M, Meggio F, Kazimierczuk Z, Pinna LA (2004) Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. J Med Chem 47(25):6239-6247 (Pubitemid 39587248)
19. Prudent R, Moucadel V, Lopez-Ramos M, Aci S, Laudet B, Mouawad L, Barette C, Einhorn J, Einhorn C, Denis JN, Bisson G, Schmidt F, Roy S, Lafanechere L, Florent JC, Cochet C (2008) Expanding the chemical diversity of CK2 inhibitors. Mol Cell Biochem 316:71-85
20. Nie Z, Perretta C, Erickson P, Margosiak S, Lu J, Averill A, Almassy R, Chu S (2008) Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities. Bioorg Med Chem Lett 18(2):19-23
21. Najda-Bernatowicz A, Łebska M, Orzeszko A, Kopańska K, Krzywińska E, Muszyńska G, Bretner M (2009) Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide - potential inhibitors of human protein kinase CK2. Bioorg Med Chem 17(4):1573-1578
22. Tsukamoto G, Yoshino K, Kohno T, Ohtaka H, Kagaya H, Ito K (1980) Synthesis and antiinflammatory activity of some 2-(substituted-pyridinyl) benzimidazoles. J Med Chem 23:734-738 (Pubitemid 10078468)
23. Charton J, Girault-Mizzi S, Debreu-Fontaine MA, Foufelle F, Hainault I, Bizot-Espiard JG, Caignardc DH, Sergheraerta Ch (2006) Synthesis and biological evaluation of benzimidazole derivatives as potent AMP-activated protein kinase activators. Bioorg Med Chem 14:4490-4518 (Pubitemid 43728675)
24. Bigelow LA (1919) A study of side chain oxidations with potassium permanganate. J Am Chem Soc 41(10):1559-1581
25. Kumar BV, Reddy VM (1985) Cyanoethylation of benzimidazoles: synthesis and biological activities of some new 1-(β-cynaoethyl)benzimidazoles and their derivatives. Indian J Chem 24B:1098-1101
26. Sreenivasa R, Mundla SR (2000) Regioselective synthesis of 4-halo ortho-dinitrobenzene derivates. Tetrahedron Lett 41: 4277-4279 (Pubitemid 30414407)
27. Altau K, Beasley JG, Pine HJ, Crawford RH, Tucker WT, Brown AD, Capps JD (1963) Some derivatives of ethylbenzene. J Chem Eng Data 8(1):122-130
28. Dirk SM, Tour JM (2003) Synthesis of nitrile-terminated potential molecular electronic devices. Tetrahedron 59:287-293 (Pubitemid 36050799)
29. Sakamoto T, Kondo Y, Iwashita S, Yamanaka H (1987) Condensed heteroaromatic ring systems. XII. Synthesis of indole derivatives from ethyl 2-bromocarbanilates. Chem Pharm Bull 35(5):1823-1828